Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label ADME study of [14C]-labeled SLV334 after single intravenous infusion
NL-OMON34670Active, not recruiting
- Sponsor
- Solvay
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of slv-334 in traumatic brain injury (TBI), sponsored by Solvay. Primary endpoints: Pharmacokinetic variables and excretion balance of total 14C-radioactivity and Metabolic profile of SLV334 and metabolites. Started Mar 2010; status: active, not recruiting.
02
Drugs
slv-334
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NL-OMON34670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34670.